| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
BASIC SCIENCE |



*Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan; and
Molecular and Cellular Nephrology, Institute of Medical Sciences and Department of Medicine, Tokai University School of Medicine, Tokyo, Japan.
Correspondence to Dr. Masaomi Nangaku, University of Tokyo School of Medicine, Division of Nephrology and Endocrinology, 7-3-1 Hongo Bunkyo-Ku, Tokyo, Japan. Phone: 03-3815-5411 ext. 33004; Fax: 03-5800-8806; E-mail mnangaku-tky{at}umin.ac.jp
| Abstract |
|---|
|
|
|---|
, and by increased transcription of hypoxia-responsive genes. Physiologic perfusion status of the postglomerular peritubular capillary network was evaluated by lectin perfusion and Hoechst 33342 diffusion techniques. Results showed that the number of hypoxic tubules was markedly increased 4 and 7 d after nephron loss. These findings antedated any histologic evidence of tubulointerstitial damage. The hypoxic state persisted until interstitial damage developed. These results were confirmed using HIF-1
immunoprecipitation and increase of hypoxia-responsive genes. Pathologic studies of the vasculature demonstrated significant functional changes that generated a hypoxic milieu. ARB treatment prevented vascular changes and ameliorated tubular hypoxia. These results suggest that the initial tubulointerstitial hypoxia in remnant kidney model plays a pathogenic role in the subsequent development of tubulointerstitial injury. The initial hypoxia in this model was dependent on activation of the renin-angiotensin system and hemodynamic alterations after nephron loss. | Introduction |
|---|
|
|
|---|
Chronic tissue hypoxia is regarded as a contributing factor in the progression of renal failure (5). Loss of peritubular capillaries in the late phase of various disease models has been recently reported (611), giving indirect evidence of renal hypoxia. Hypoxia itself can initiate the inflammatory process and eventually lead to tissue fibrosis (1217). In a remnant kidney model, Kang et al. (11) reported that the loss of peritubular capillaries occurred around the second week, at which time severe tubulointerstitial injury started to develop. Prevention of this loss by VEGF administration abolished subsequent tubulointerstitial damage. These data strongly support the notion that hypoxia might be a cause, rather than an epiphenomenon, of tubulointerstitial damage. However, evidence of hypoxia in the early phase of this representative model before the development of histologic damage remains to be clarified. We have investigated the hypothesis that hemodynamic alterations might lead to tubulointerstitial hypoxia in the very early phase in this model, which might in turn induce tubulointerstitial damage and lead to eventual kidney failure.
To prove this hypothesis, we designed the current study to look for evidence of hypoxia within the first week after renal mass reduction. At this time point, hemodynamic alterations are well established but tubulointerstitial damage is negligible (18). Here, findings showed that many tubules suffer from hypoxic conditions in the early phase of remnant kidney. Furthermore, hypoxia in the tubulointerstitial compartment preceded traditional evidence of tubulointerstitial damage and persisted until the damage developed. Investigations utilizing angiotensin II receptor blockage (ARB) suggested that the tubular hypoxia was dependent on the activation of RAS.
| Materials and Methods |
|---|
|
|
|---|
Antibodies
Monoclonal mouse anti-human
-smooth muscle actin (
-SMA) 1:1000 (Boehringer Mannheim, Mannheim, Germany), mouse antipimonidazole 1:200 (Chemicon, Temecula, CA), mouse anti-rat vimentin 1:1000 (Dako, Glostrup, Denmark), biotinylated anti-mouse Ig 1:400 (Vector Laboratories, Burlingame, CA), and alkaline phosphatase-conjugated anti-mouse IgG 1:1000 (Promega, Madison, WI) were used in immunohistochemical studies. Monoclonal mouse anti-human HIF-1
1:1000 (Novus Biologic, Littleton, CO) was used in immunoprecipitation studies.
Disease Model and Experimental Protocol
Eight rats served as a sham-operated control (sham group), and 36 underwent 5/6 nephrectomy as described previously (19). In brief, after right subcapsular nephrectomy, infarction of approximately two thirds of the left kidney was accomplished by ligation of the posterior and one or two anterior extrarenal branches of the main left renal artery. Sixteen of these animals received an ARB, olmesartan (Pharmacology and Molecular Biology Research Laboratories, Sankyo Pharmaceutical, Tokyo, Japan), at a dosage of 10 mg/kg per d (20) by gastric gavage (RK+ARB group). The remaining animals were not treated with this reagent (RK group, n = 20). Treatment was started the day after operation and continued until the day of sacrifice. Eight rats each from the RK and RK+ARB groups were sacrificed at 4 and 7 d (early phase) after the operation and designated as the 4d RK, 7d RK, 4d RK+ARB, and 7d RK+ARB groups, respectively. Sham animals were sacrificed on day 7. The four remaining rats in the RK group were killed at 2 wk to examine the persistence of findings (extended RK). Twenty-four-hour urine and tail vein blood were collected before sacrifice. To detect hypoxia, 60 mg/kg of hypoxic probe, pimonidazole (Chemicon), was injected intraperitoneally 2 h before sacrifice (2123). To demonstrate functioning vessels, 250 µg of biotinylated lectin (Lycopersicon esculentum Lectin, Vector Laboratories) was injected via the tail vein exactly 4 min before sacrifice (24). To study the tissue perfusion properties of each vessel, 15 mg/kg of bisbezamine (Hoechst 33342; Sigma Chemical, St. Louis, MO) was injected via the inferior vena cava just below the left renal vein. Exactly 30 sec after injection, the renal pedicle was clamped and the kidney was promptly removed (25). To maintain the most representative perfusion patterns of vessels, all materials were intentionally injected without the use of a pressure pump. Kidney tissues for analysis were carefully selected to exclude necrotic areas. One sample of kidney tissue was fixed in methyl Carnoys fixative and then embedded in paraffin. All specimens were stored in light-protected containers. A second piece of the kidney was dissected in ice-cold PBS, and the medulla was removed, which was then snap-frozen in liquid nitrogen before transfer to storage at 80°C until further analysis.
To validate our methodology of Hoechst dye perfusion, 12 additional rats were studied as described below in Nuclear Fluorescence Studies of Tissue Perfusion Properties of this section. Three of these animals underwent renal artery stenosis according to a model described previously (17), three underwent 6-wk 5/6 nephrectomy, three served as a sham-operated control, and three were examined without administration of the Hoechst dye.
Double and Triple Immunohistochemical Analysis
Immunohistochemical staining was performed as described previously (26). Avidin HRP was used to stain biotinylated lectin-perfused vessels. Chromogenic color was developed with 3,3'diaminobenzidine tetrahydrochloride (DAB). After staining the first antigen, the remaining peroxidase activity was extinguished with 3% H2O2 in methanol for 10 min. The remaining biotin was blocked by incubation with avidin solution (Vector Laboratories), after which the first antibodies for the second antigen were applied, followed by suitable secondary antibodies (biotinylated or alkaline phosphatase-conjugated). Color was developed with DAB plus 0.8% nickel or Vector Red (Vector Laboratories). When alkaline phosphatase reaction was used, endogenous alkaline phosphatase was blocked with levamisole solution (Vector Laboratories). The processes were repeated for the third antigen staining. Negative controls without first antibodies were carefully examined for each reaction. All histologic slides were examined by light microscopy using an Olympus BX51 (Tokyo, Japan), and pictures were taken with the Olympus DP12 system. In some experiments, nuclei were counter-stained with methyl green (Vector Laboratories).
Nuclear Fluorescence Studies of Hoechst Dye to Investigate Tissue Perfusion Properties
For indirect comparison of tissue perfusion properties of Hoechst dye, 4-µm sections of paraffin-embedded tissues were stepwise rehydrated in a light-protected container. Rehydrated tissues were mounted and immediately photographed at 600x magnification (Eclipse E600, Nikon, Tokyo, Japan; connected to a cool charge-couple device [CCD], Micromax, Princeton Instruments, Trenton, NJ, and Metamorph, Downingtown, PA) avoiding any part of the glomeruli. In this step, the exposure time was fixed at 50 msec and the CCD temperature was set below 10°C.
Semiquantitative Scoring System
All scoring was done in a blinded manner. Photographs were examined in gray scale. Tubulointerstitial injuries in the cortex were scored in a blinded manner on 20 randomly selected non-overlapping 200x fields per rat on periodic acid-Schiff (PAS) and Trichrome Masson staining sections as described previously (11). Semiquantitative scores for pimonidazole adduction,
-SMA expression, and tubular vimentin expression were evaluated from 20 nonoverlapping fields at 200x magnification from each rat according to the following scoring method: 0, no involvement; 1, involvement of <10% of the cortex; 2, involvement of 10% to 25% of the cortex; 3, involvement of 26% to 50% of the cortex; 4, involvement of 51% to 75% of the cortex; and 5, involvement of >75% of the cortex.
The amount of postglomerular peritubular capillaries was evaluated by the vascular rarefaction index and the number of capillary lumina per 100 tubules by detection of perfused lectin as described previously (7,11). Measurement of capillary luminal areas was done using 10 randomly selected 400x pictures per rat (334.2 ± 55 lumina/animal) in a blinded manner with the Image J software (http://rsb.info.nih.gov/ij/).
Perfusion status with the nucleus-staining Hoechst dye was evaluated using Photoshop, version 7.0 (Adobe, San Jose, CA), as follows. Pictures were normalized by decreasing background signals of autofluorescence of tubular cell cytoplasm to undetectable levels (27,28). Nuclei were selected with the Wand tool of Photoshop, which automatically selects areas of nuclei. A mean log scale of luminosity of selected areas from each picture was then measured by the histogram function. Our preliminary studies of a renal artery stenosis model (n = 3) showed almost undetectable parenchymal nuclear fluorescence. Mean nuclear luminosity of 6-wk remnant kidney animals (n = 3) was 63 ± 8.6. Nuclear luminosity of sham-operated animals (n = 3) by this method was 121.9 ± 4.3, and background luminosity of non-injected animals (n = 3) was 0.34 ± 0.2.
Proliferation of endothelial cells was evaluated on double-staining of perfused lectin and PCNA by counting PCNA-positive nuclei per thousand visualized cortical capillary lumina from each rat.
Immunoprecipitation of HIF-1
To confirm that remnant kidneys were hypoxic, 20 mg of protein of homogenized cortical tissues of each animal was subjected to protein A Sepharose immunoprecipitation (Amersham International, Buckingham, UK) according to the manufacturers protocol (29). The precipitated protein was separated by electrophoresis in 8% SDS-PAGE gel or 4 to 20% SDS-PAGE gradient gel (Diaichi Pure Chemical, Tokyo, Japan), followed by electrotransfer to PVDF membranes (Amersham International). Transfer membranes were blocked with 5% nonfat milk in TBS, 0.01% Tween-20, for 30 min at room temperature. The membranes were then blotted with anti-HIF1
antibody (Novus Biologic) at 1:100 at room temperature for 2 h. The bound antibodies were detected with alkaline phosphatase-conjugated secondary antibodies. 5-Bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium tablets (Sigma Fast; Sigma Chemical) were used as a chromogenic substrate.
Total RNA Isolation and Real-Time RT-PCR
Total RNA from cortical tissues from each rat was isolated with Isogen according to the manufacturers protocol (Wako Chemical, Osaka, Japan). cDNA synthesis was carried out with 2 µg of isolated RNA at 42°C for 1 h with an oligoDT Inpromp-II kit (Promega). One microgram of cDNA was subjected to real-time PCR (iCycler iQ; Bio-Rad, Hercules, CA) utilizing Syber Green Supermix (Bio-Rad) with the correspondence primers as follows:
-actin: 5'-CTTTCTACAATGAGCTGCGTG-3', 5'-TCATGAGGTAGTCTGTCAGG-3'; erythropoietin (EPO): 5'-TACGTAGCCTCACTTCACTGCTT-3', 5'-GCAGAAAGTATCCGCTGTGAGTGTTC-3'; Glucose transporter-1 (GLUT-1): 5'-CAGTTCGGCTATAACACCGGTGTC-3', 5'-ATAGCGGTGGTTCCATGTTT-3'; and vascular endothelial growth factor (VEGF): 5'-TTACTGCTGTACCTCCAC-3', 5'-ACAGGACGGCTTGAAGATA-3' (30). The PCR was amplified for forty cycles. Each PCR product was subjected to melting curve analysis after PCR was completed. Threshold cycles for each primer were separately analyzed. The amount of target mRNA/
-actin mRNA were calculated according to the following equation: target mRNA/
-actin mRNA = 2(tc bc) where tc and bc are threshold cycles of the target gene and
-actin, respectively. Representative data are presented in terms of fold mRNA changes compared with sham.
Statistical Analyses
All numerical data are presented as mean ± SD. Distributions of some data are shown by histogram. One-way ANOVA followed by the least significant difference (LSD) method was used to determine differences among groups for all continuous parameters. The Mann-Whitney test was applied for noncontinuous parameters. Correlations between two parameters were analyzed with Pearson correlation test. The significance level was set at P < 0.05 for all tests (SPSS for Windows 10.0).
| Results |
|---|
|
|
|---|
|
|
|
|
protein (Figure 3a). No expression of HIF-1
was detectable in the cortex in the sham group. In contrast, increased HIF-1
expression in the cortex was observed in 7d RK animals, which was consistent with the results of the pimonidazole uptake studies. RT-PCR analysis of a series of hypoxia-responsive genes also supported the presence of hypoxia in the kidney in the early phase. EPO, GLUT-1, and VEGF were markedly increased at this time point in the remnant kidneys, and ARB attenuated these changes (Figure 3b).
|
-SMA was employed to detect interstitial myofibroblasts, which are associated with interstitial damage and fibrosis. No difference between the sham and early remnant groups was seen (Figure 1, c, d, g, and h). In contrast, an increase in the number of vimentin-positive tubular cells as well as in
-SMA expression was seen in the extended phase (Table 2). These findings indicated that hypoxia during the early study period (within the first week) was unlikely to have been the result of tubulointerstitial damage.
Association of Hypoxia with Decreased Perfusion of the Peritubular Capillary Beds in the Early Phase
Because injected lectin binds to perfused endothelial cells under physiologic conditions, this method allows evaluation of both the amount of and morphologic changes in functioning postglomerular peritubular capillaries. The number of peritubular capillaries per 100 tubules and rarefaction index in 4d RK and 7d RK did not differ from that in the sham rats (Table 3). In contrast, the number of peritubular capillaries in the extended RK clearly decreased, to 137.8 ± 12.5 per 100 tubules, with rarefaction of 12 ± 3.7% (P < 0.05 versus sham). On this basis, hypoxia in the early phase could not be explained by any structural loss of peritubular capillary beds, in contrast to the extended phase, when histologic loss of peritubular capillaries was established. Notwithstanding this, significant morphologic changes in peritubular capillaries in the early stage were observed. In normal kidneys, peritubular capillaries are elliptical, circular, or triangular in cross-section, which preserves the patency of the lumina (Figure 4a). In contrast, peritubular capillaries in remnant kidney animals showed a distorted outline with relatively narrow capillary lumina (Figure 4b). Analysis of cross-sectional capillaries showed that the mean of capillary lumina area in remnant kidney animals was significantly lower than that of the control rats (Table 3). The histogram demonstrated that remnant kidney animals harbored abundant narrow capillaries (Figure 4d). Double immunostaining analysis using pimonidazole and lectin showed co-localization of narrow capillaries and hypoxic tubules (Figure 2e). This result was supported by correlation analysis (Figure 4e). Furthermore, ARB treatment preserved the structural integrity of postglomerular capillaries as well as luminal patency (Figure 4c and Table 3). These data suggested that the abnormality in peritubular capillaries might have been mediated at least in part by the activation of RAS.
|
|
|
|
| Discussion |
|---|
|
|
|---|
We intended to perform this study at the early phase after nephron loss at an equivalent time point to that used in the landmark study of Hostetter and Brenner (1), when tubulointerstitial injury is negligible despite significant changes in renal hemodynamics. On this basis, our results were accompanied by glomerular hyperfiltration but were unlikely to be the result of tubulointerstitial damage. Increased cellular adduction of pimonidazole in remnant kidney tubules suggested that these tubular cells were hypoxic. The mechanism of cellular adduction of pimonidazole specifically depends on a hypoxia-induced redox state, and previous studies have demonstrated a good correlation between adduction and tissue O2 tension (31). However, to exclude the possibility that hypertrophic tubules might adduct pimonidazole without hypoxia via unidentified mechanisms, we measured HIF-1
expression.
HIF-1
is the master hypoxia response regulator, the amount of which is determined by oxygen-dependent degradation (32). Rosenberger et al. (33) found no detectable expression of HIF-1
in the normal kidney cortex. Here, we demonstrated an increased amount of this protein in the renal cortex in remnant kidneys, confirming that the remnant kidney milieu was indeed hypoxic. We also measured changes in mRNA levels of hypoxia-responsive genes, including EPO, GLUT-1, and VEGF. All these genes contain hypoxia-response elements (HRE) in their cis-regulatory promoter regions (30) and increase their transcription in the presence of hypoxia. Although the possibility of non-hypoxic transcriptional regulation of HIF-1 cannot be excluded (34), the upregulation of HIF and these hypoxia-responsive genes, together with the results using a hypoxia marker and the evaluation of tissue perfusion status, all point to the establishment of local hypoxia in our studies.
Previous studies suggest that kidney injury in the early phase is dependent on hemodynamic changes, whereas tubulointerstitial damage in the late phase is mediated by massive proteinuria (35). Development of tubulointerstitial hypoxia in the very early phase suggests its possible pathogenic role in tubulointerstitial injury at this stage. Basile et al. (22) reported that kidneys did not fully recover after severe ischemic acute renal failure and that this lack of recovery was associated with the loss of peritubular capillaries and an increase in tubular pimonidazole adduction. Suga et al. (23) also showed increased adduction of pimonidazole in a hypokalemic nephropathy model with tubulointerstitial injury. Using BOLD MRI, Ries et al. (36) reported hypoxia in the renal cortex of diabetic rats in the early hyperfiltration phase. Recent studies by Johnson et al. (37) demonstrated that chronic systemic hypoxia causes renal interstitial damage. Previous work by Truong group (38) and our group (17) on kidneys subject to renal artery stenosis also supported a role of hypoxia in tubulointerstitial injury. In contrast to these previous and our present findings, Priyadarshi et al. (39) performed direct measurement of tissue oxygen tensions by microelectrode in the late phase of a remnant kidney model and reported a relative increase in tissue oxygen tension. The reason for this discrepancy is unclear, but the microelectrode method may have detected regional hyperoxia. An alternative explanation may be the difference in studys time point.
The finding of tubular hypoxia in the early phase stimulated us to investigate the responsible mechanisms. Intravenous injection of biotinylated lectin under physiologic conditions, which allows evaluation of the amount and structure of functioning capillaries (24), showed no changes in the number of capillaries per tubule or vascular rarefaction at our early time points, but it did reveal striking morphologic changes in the capillary network pattern. Many peritubular capillaries in remnant kidney animals were distorted and collapsed, showing a streak-like appearance. Quantitative analysis showed that remnant kidney harbored a large number of narrow peritubular capillaries. Furthermore, correlation analysis showed that the degree of capillary narrowing was related to that of pimonidazole adduction. Of interest, the narrowing of peritubular capillaries had been previously reported in several human diseases (6,40). It should be emphasized that the flow in individual capillary beds is dynamic but under the tight regulation of an active feedback system and that the diameter of a vessel is the primary determinant of its flow (41); we therefore speculate that these peritubular capillary changes may be related to poor tissue perfusion, leading to hypoxia. A second experiment provided indirect support for this speculation; on measurement of tissue perfusion by injection of nuclear dye, a well-established method in oncology research (25,27,28,42), remnant kidney animals showed a decrease in tubulointerstitial nuclear fluorescence signals.
Neoangiogenesis is a common response to chronic hypoxia. Kang et al. (11) and Pillebout et al. (43) reported transient endothelial proliferation, which may be considered as a component of neoangiogenesis, in a remnant kidney model while Ohashi et al. (7) observed this phenomenon in a unilateral ureteral obstruction (UUO) model. A recent study by Rosenberger et al. (44) suggested that hypoxia might stimulate peritubular capillary endothelial proliferation. Our results also revealed that endothelial proliferation co-localized with areas of hypoxia, suggesting that endothelial proliferation (in this model) might be another response to hypoxia.
Activation of RAS is the earliest humoral response after nephron loss (45), and several clinical studies have shown that angiotensin-converting enzyme inhibitors (ACEI) and ARB effectively attenuate the progression of kidney disease (46,47). Our results revealed that ARB attenuated pimonidazole adduction in tubular cells and preserved peritubular capillary network structure. The expression of hypoxia-responsive genes was also decreased in ARB-treated animals, suggesting that tubulointerstitial hypoxia in remnant kidneys is mediated by the activation of RAS, possibly via their vasoconstrictive effects on efferent arterioles. This speculation is supported by recent findings by Norman et al. (48), who showed that treatment with ACEI and ARB increased cortical tissue O2 tension and proposed that this might be another renoprotective role of these drugs. In addition, Fujimoto et al. (49) reported that chronic angiotensin infusion resulted in a decrease in peritubular blood flow, which was accompanied by adduction of pimonidazole. Taken together, these and the present results emphasize the role of RAS activation in the disturbance of tubulointerstitial microcirculation and subsequent hypoxia. Moreover, they support the notion that improvement of cortical tissue oxygenation might be another renoprotective property of ARB and ACEI.
In conclusion, we have demonstrated that the hypoxic milieu in the tubulointerstitium precedes any pathologic change in the corresponding region, suggesting a pathogenic role of ischemia at early time points. Our results suggested that perfusion was decreased in peritubular capillaries in association with hypoxia in the tubulointerstitium in the early phase of remnant kidney models, and these changes may be mediated by the activation of RAS.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
1 independent mechanism. Kidney Int 52: 637647, 1997[Medline]
This article has been cited by other articles:
![]() |
R. Shibata, S. Ueda, S.-i. Yamagishi, Y. Kaida, Y. Matsumoto, K. Fukami, A. Hayashida, H. Matsuoka, S. Kato, M. Kimoto, et al. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy Nephrol. Dial. Transplant., November 17, 2008; (2008) gfn630v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Evans, B. S. Gardiner, D. W. Smith, and P. M. O'Connor Intrarenal oxygenation: unique challenges and the biophysical basis of homeostasis Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1259 - F1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kimura, M. Iwano, D. F. Higgins, Y. Yamaguchi, K. Nakatani, K. Harada, A. Kubo, Y. Akai, E. B. Rankin, E. G. Neilson, et al. Stable expression of HIF-1{alpha} in tubular epithelial cells promotes interstitial fibrosis Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1023 - F1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Wong, Y. Suzuki, C. Tanifuji, H. Akiba, K. Okumura, T. Sugaya, T. Yamamoto, S. Horikoshi, S. Y. Tan, C. Pollock, et al. Peritubular Ischemia Contributes More to Tubular Damage than Proteinuria in Immune-Mediated Glomerulonephritis J. Am. Soc. Nephrol., February 1, 2008; 19(2): 290 - 297. [Full Text] [PDF] |
||||
![]() |
R. Zeng, Y. Yao, M. Han, X. Zhao, X.-C. Liu, J. Wei, Y. Luo, J. Zhang, J. Zhou, S. Wang, et al. Biliverdin Reductase Mediates Hypoxia-Induced EMT via PI3-Kinase and Akt J. Am. Soc. Nephrol., February 1, 2008; 19(2): 380 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kondo, H. Kiyomoto, T. Yamamoto, A. Miyatake, G.-P. Sun, M. Rahman, H. Hitomi, K. Moriwaki, T. Hara, S. Kimura, et al. Effects of Calcium Channel Blockade on Angiotensin II-Induced Peritubular Ischemia in Rats J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1047 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nangaku Chronic Hypoxia and Tubulointerstitial Injury: A Final Common Pathway to End-Stage Renal Failure J. Am. Soc. Nephrol., January 1, 2006; 17(1): 17 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Izuhara, M. Nangaku, R. Inagi, N. Tominaga, T. Aizawa, K. Kurokawa, C. van Ypersele de Strihou, and T. Miyata Renoprotective Properties of Angiotensin Receptor Blockers beyond Blood Pressure Lowering J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3631 - 3641. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Eto, I. Kojima, N. Uesugi, R. Inagi, T. Miyata, T. Fujita, R. J. Johnson, S. J. Shankland, and M. Nangaku Protection of Endothelial Cells by Dextran Sulfate in Rats with Thrombotic Microangiopathy J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2997 - 3005. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saemann, T Weichhart, M Zeyda, G Staffler, M Schunn, K. Stuhlmeier, Y Sobanov, T. Stulnig, S Akira, A von Gabain, et al. Immunoregulation in Urinary Tract Inflammation--A Role of Tamm-Horsfall Glycoprotein: Tamm-Horsfall Glycoprotein Links Innate Immune Cell Activation with Adaptive Immunity via a Toll-Like Receptor-4-Dependent Mechanism. J Clin Invest 115: 468-475, 2005 J. Am. Soc. Nephrol., April 1, 2005; 16(4): 829 - 836. [Full Text] [PDF] |
||||
![]() |
T. Tanaka, T. Miyata, R. Inagi, T. Fujita, and M. Nangaku Hypoxia in Renal Disease with Proteinuria and/or Glomerular Hypertension Am. J. Pathol., December 1, 2004; 165(6): 1979 - 1992. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Higgins, M. P. Biju, Y. Akai, A. Wutz, R. S. Johnson, and V. H. Haase Hypoxic induction of Ctgf is directly mediated by Hif-1 Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1223 - F1232. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||